Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 67886

1.

Recommendations and barriers to vaccination in systemic lupus erythematosus.

Garg M, Mufti N, Palmore T, Hasni S.

Autoimmun Rev. 2018 Aug 10. pii: S1568-9972(18)30178-2. doi: 10.1016/j.autrev.2018.04.006. [Epub ahead of print] Review.

PMID:
30103044
2.

Clinical and immunological parameters of Sjögren's syndrome.

Psianou K, Panagoulias I, Papanastasiou AD, de Lastic AL, Rodi M, Spantidea PI, Degn SE, Georgiou P, Mouzaki A.

Autoimmun Rev. 2018 Aug 10. pii: S1568-9972(18)30188-5. doi: 10.1016/j.autrev.2018.05.005. [Epub ahead of print] Review.

PMID:
30103041
3.

Genetic association between HLA-G 14-bp polymorphism and diseases: a systematic review and meta-analysis.

de Almeida BS, Muniz YCN, Prompt AH, Castelli EC, Mendes-Junior CT, Donadi EA.

Hum Immunol. 2018 Aug 10. pii: S0198-8859(18)30637-2. doi: 10.1016/j.humimm.2018.08.003. [Epub ahead of print]

PMID:
30102938
4.

Progression of subclinical atherosclerosis in systemic lupus erythematosus versus rheumatoid arthritis: the impact of low disease activity.

Kravvariti E, Konstantonis G, Sfikakis PP, Tektonidou MG.

Rheumatology (Oxford). 2018 Aug 8. doi: 10.1093/rheumatology/key233. [Epub ahead of print]

PMID:
30102390
5.

The DNA-polymorphism rs849142 is associated with skin toxicity induced by targeted anti-EGFR therapy using cetuximab.

Froelich MF, Stintzing S, Kumbrink J, Grünewald TGP, Mansmann U, Heinemann V, Kirchner T, Jung A.

Oncotarget. 2018 Jul 13;9(54):30279-30288. doi: 10.18632/oncotarget.25689. eCollection 2018 Jul 13.

6.

Immunosuppressive/Autoimmune Disorders.

Richard-Eaglin A, Smallheer BA.

Nurs Clin North Am. 2018 Sep;53(3):319-334. doi: 10.1016/j.cnur.2018.04.002. Review.

PMID:
30099999
7.

Linear gingival erythema in a child with systemic lupus erythematosus: an association or a coincidence?

Gupta A, Sharma A, Pilania RK, Suri D.

Lupus. 2018 Aug 12:961203318793217. doi: 10.1177/0961203318793217. [Epub ahead of print] No abstract available.

PMID:
30099943
8.

Stem cells for lupus nephritis: a concise review of current knowledge.

Sattwika PD, Mustafa R, Paramaiswari A, Herningtyas EH.

Lupus. 2018 Aug 12:961203318793206. doi: 10.1177/0961203318793206. [Epub ahead of print]

PMID:
30099942
9.

Incidence of cardiovascular risk factors in female patients with systemic lupus erythematosus: a 3-year follow-up cohort.

Monção CSA, Martins LN, Penteado MPS, Reis RCP, Santos FMM, Lanna CCD, Ribeiro AL, Telles RW.

Lupus. 2018 Aug 12:961203318790676. doi: 10.1177/0961203318790676. [Epub ahead of print]

PMID:
30099941
10.

Lupus anticoagulant hypoprothrombinemia syndrome associated with systemic lupus erythematosus in children: report of two cases and systematic review of the literature.

Pilania RK, Suri D, Jindal AK, Kumar N, Sharma A, Sharma P, Guleria S, Rawat A, Ahluwalia J, Singh S.

Rheumatol Int. 2018 Aug 11. doi: 10.1007/s00296-018-4127-9. [Epub ahead of print] Review.

PMID:
30099593
11.

Adipokine interactions promote the pathogenesis of systemic lupus erythematosus.

Chougule D, Nadkar M, Venkataraman K, Rajadhyaksha A, Hase N, Jamale T, Kini S, Khadilkar P, Anand V, Madkaikar M, Pradhan V.

Cytokine. 2018 Aug 8;111:20-27. doi: 10.1016/j.cyto.2018.08.002. [Epub ahead of print]

PMID:
30098476
12.

Reply to the letter by Pindado-Ortega et al.

Kuhn A, Skrobal M, Volc-Platzer B.

J Eur Acad Dermatol Venereol. 2018 Aug 11. doi: 10.1111/jdv.15210. [Epub ahead of print]

PMID:
30098057
13.

Trans-Ethnic Mapping of BANK1 Identifies Two Independent SLE-Risk Linkage Groups Enriched for Co-Transcriptional Splicing Marks.

Martínez-Bueno M, Oparina N, Dozmorov MG, Marion MC, Comeau ME, Gilkeson G, Kamen D, Weisman M, Salmon J, McCune JW, Harley JB, Kimberly R, James JA, Merrill J, Montgomery C, Langefeld CD, Alarcón-Riquelme ME.

Int J Mol Sci. 2018 Aug 8;19(8). pii: E2331. doi: 10.3390/ijms19082331.

14.

Ocular Involvement in Systemic Lupus Erythematosus: The Experience of Two Tertiary Referral Centers.

Dammacco R, Procaccio P, Racanelli V, Vacca A, Dammacco F.

Ocul Immunol Inflamm. 2018 Aug 10:1-12. doi: 10.1080/09273948.2018.1501495. [Epub ahead of print]

PMID:
30096011
15.

NMR-based Serum Metabolomics of patients with Takayasu arteritis (TA) - Relationship with disease activity.

Jain A, Kumar D, Guleria A, Misra DP, Zanwar A, Chaurasia S, Kumar S, Kumar U, Mishra SK, Goel R, Danda D, Misra R.

J Proteome Res. 2018 Aug 10. doi: 10.1021/acs.jproteome.8b00456. [Epub ahead of print]

PMID:
30095916
16.

Seronegative cat scratch disease in a patient with systemic lupus erythematosus.

Aguiar F, Martins-Rocha T, Rodrigues M, Brito I.

Acta Reumatol Port. 2018 Aug 10. [Epub ahead of print] No abstract available.

PMID:
30095802
17.

Non-albumin proteinuria as a parameter of tubulointerstitial inflammation in lupus nephritis.

Kwon OC, Park Y, Lee JS, Oh JS, Kim YG, Lee CK, Yoo B, Hong S.

Clin Rheumatol. 2018 Aug 9. doi: 10.1007/s10067-018-4256-2. [Epub ahead of print]

PMID:
30094751
18.

Angiotensin II type 1 receptor gene polymorphism and serum angiotensin-converting enzyme level in Egyptian children with systemic lupus erythematosus.

Shoaib RMS, Hammad A, Yahia S, Elsaid A, Abdel-Malak CA.

Clin Rheumatol. 2018 Aug 9. doi: 10.1007/s10067-018-4255-3. [Epub ahead of print]

PMID:
30094750
19.

Epidemiology and management practices for childhood-onset systemic lupus erythematosus patients: a survey in Latin America.

Ferreira JCOA, Trindade VC, Espada G, Morel Z, Bonfá E, Magalhães CS, Silva CA.

Clin Rheumatol. 2018 Aug 9. doi: 10.1007/s10067-018-4254-4. [Epub ahead of print]

PMID:
30094748
20.

M2 macrophages and their role in rheumatic diseases.

Bhattacharya S, Aggarwal A.

Rheumatol Int. 2018 Aug 9. doi: 10.1007/s00296-018-4120-3. [Epub ahead of print] Review.

PMID:
30094684

Supplemental Content

Loading ...
Support Center